Since 1995, Reliable Business Intelligence for Clinical Laboratories, Pathology Groups and Laboratory Diagnostics

TAG:

dna sequencing

PacBio Beefs Up with Purchase of Omniome for $800 Million

FORWARD-LOOKING PATHOLOGISTS AND LAB ADMINISTRATORS understand that the next big game in medical laboratory testing will be assays built upon genome sequencing. They also know that several companies are racing to produce gene sequencing instruments that are faster, simpler, and less costly in order t…

Read More



Several Big Surprises in 2018ā€™s Top 10 Lab Stories

CEO SUMMARY: This yearā€™s list of the Top 10 Lab Industry Stories for 2018 is dominated by new directives from Medicare and private health insurers, as well as significant decisions by federal courts. Collectively, these developments create new compliance risks for all clinical laborator…

Read More



Illumina to Pay $1.2 Billion to Acquire Pacific Biosciences

IT’S AN ACQUISITION THAT BRINGS TOGETHER two different gene sequencing technologies into one firm. On Nov. 1, Illumina, Inc., announced an agreement to acquire Pacific BiosciencesĀ (PacBio) for $1.2 billion. This deal will bolster Illuminaā€™s already-dominant posit…

Read More



More Primary Care Docs Will Offer Genetic Tests

CEO SUMMARY: This summer, both Geisinger Health and Sanford Health will introduce genetic tests designed specifically for use by primary care physicians in their daily practice. This is a significant milestone on the road to wider deployment of precision medicine services. In the case of …

Read More



February 29, 2016 Intelligence: Late Breaking Lab News

Sandy, Utah-based SureĀ Genomics is the latest genetic testing company to get a letter from the Food and Drug Administration asking why the company is marketing its SureDNA genetic testing kit to consumers without first obtaining clearance from the federal agency. Th…

Read More



August 24, 2015 Intelligence: Late Breaking Lab News

California is always in the forefront of states doing innovative things. It announced a public-private effort to develop a clinical laboratory assay that ā€œwill enable detection of all known pathogens with a single DNA sequencing test, to diagnose acute infections in hospitalized patients.ā€ Fundin…

Read More



More Genetic Counseling Leads to Fewer Lab Tests

CEO SUMMARY: Cigna was the first national health insurerĀ to require independent board-certified genetic counselingĀ before approving coverage for certain genetic tests. SinceĀ launching this program in September 2013, the insurer has seenĀ a 450% increase in genetic counseling for Cigna …

Read More



Whole Genome Sequencing Is Poised for Clinical Use

CEO SUMMARY: Pathologists and clinical lab managers interested in following the advances in use of whole human genome sequencing for clinical purposes should follow the money. Within weeks of obtaining FDA clearance for its MiSeqDx system and reagents, Illumina had inked major agreements …

Read More



Cigna Program Addresses Genetic Test Utilization

CEO SUMMARY: Cigna launched a program that requires genetic counseling for patients and pre-authorization of genetic tests. Its partner is InformedDNA, a firm that provides genetic counseling services. The goals include better patient engagement, improved test utilization…

Read More



Cleveland Clinic Lab Aims to Grow Reference Testing

CEO SUMMARY: In the national market for reference and esoteric testing, Cleveland Clinic Laboratories (CCL) is preparing to expand its presence. It has just moved into a $75 million state-of-the-art laboratory facility and wants to increase its outreach reference testing by four-fold with…

Read More



How Much Laboratory Business Intelligence Have You Missed?

Lab leaders rely on THE DARK REPORT for actionable intelligence on important developments in the business of laboratory testing. Maximize the money you make-and the money you keep! Best of all, it is released every three weeks!

Sign up for TDR Insider

Join the Dark Intelligence Group FREE and get TDR Insider FREE!
Never miss a single update on the issues that matter to you and your business.

;